Macular Edema as Unusual Presentation of Non-Arteritic Ischemic Optic Neuropathy (NAION)
Article Sidebar
Main Article Content
Abstract
Introduction: Non-arteritic Ischemic Optic Neuropathy is the most common type of ischemic optic neuropathy. Nearly half of NAION patients presented with 20/30 or better visual acuity. Central vision is often preserved relative to the visual field loss. Macular edema in NAION patient is rare, and its occurrence may confuse to other disease and lead to unnecessary treatment.
Case Report: We identified three NAION patients presented with macular edema. The patients' age was above 40 and had diabetes mellitus (DM). Our patients had clinical findings consistent with NAION with poor visual acuity at the early presentation. Optical coherence tomography examination was performed, and all patients had prominent subretinal fluid. Intravitreal anti-VEGF injection was done on our first patient and no treatment was given to our second and third patient. All patients showed a significant improvement of macular edema.
Discussion: Macular edema is a rare clinical manifestation that may contribute a visual deterioration in NAION. The incidence of macular edema in NAION patients is difficult to measure since OCT of macula is not routinely performed. In our report, we encountered three cases of NAION complicated by macular edema that underwent a different approach in therapy. Spontaneous regression of subretinal fluid was seen during observation without any treatment given. Our patients achieved a stable visual acuity and visual field defect. This finding is under the literature that spontaneous recovery will be observed during the natural course of acute NAION.
Conclusion: Macular edema is an unusual but self-limiting presentation of NAION. Therefore, a comprehensive examination is needed to prevent any unnecessary treatment.
Keywords
Non-arteritic ischemic optic neuropathy, macular edema, subretinal fluid
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
2. The patient with decreased vision: classification and management. In: American Academy of Ophthalmology Basic and clinical science course section 5: Neuro-ophthalmology. United States: American Academy of Ophthalmology; 2019.
3. Berry S, Lin W V, Lee AG. Nonarteritic anterior ischemic optic neuropathy : cause , effect , and management. 2017;23–8.
4. Donmez O, Kocaoglu G, Yaman A, Bajin MS, Saatci AO. Macular Evaluation wıth Spectral Domain Type Optic Coherence Tomography in Eyes with Acute Nonarteritic Ischemic Optic Neuropathy at the Presentation Visit. Open Ophthalmol J. 2017;11(1):17–23.
5. Huemer J, Khalid H, Ferraz D, Faes L, Korot E, Jurkute N, et al. Re-evaluating diabetic papillopathy using optical coherence tomography and inner retinal sublayer analysis. Eye [Internet]. 2021;(March):1–10. Available from: http://dx.doi.org/10.1038/s41433-021-01664-1
6. Gaier ED, Torun N. The enigma of nonarteritic anterior ischemic optic neuropathy: An update for the comprehensive ophthalmologist. Curr Opin Ophthalmol. 2016;27(6):498–504.
7. Demirel S, Batioǧlu F, Oguz YG, Özmert E. Macular involvement and response to steroid therapy demonstrated by optical coherence tomography in non-arteritic anterior ischaemic optic neuropathy. Neuro-Ophthalmology. 2013;37(4):161–4.
8. González-Martín-Moro J, Fernández-Hortelano A, Castro-Rebollo M, Pilo-de-la-Fuente B. Visual worsening despite resolution of subfoveal fluid in nonarteritic ischemic optic neuropathy. Can J Ophthalmol [Internet]. 2017;52(6):e218–20. Available from: http://dx.doi.org/10.1016/j.jcjo.2017.05.002
9. Tsai MJ, Hsieh YT, Shen EP, Peng YJ. Systemic Associations with Residual Subretinal Fluid after Ranibizumab in Diabetic Macular Edema. J Ophthalmol. 2017;2017.
10. Hayreh SS. Ischemic optic neuropathies - Where are we now? Graefe’s Arch Clin Exp Ophthalmol. 2013;251(8):1873–84.
11. Takayama K, Kaneko H, Kachi S, Ra E, Ito Y, Terasaki H. High-dose intravenous pulse steroid therapy for optic disc swelling and subretinal fluid in non-arteritic anterior ischemic optic neuropathy. Nagoya J Med Sci. 2017;79(1):103–8.
12. Joussen AM, Stitt A, Lois N. Mechanisms of Macular Edema and Therapeutic Approaches. In: Schachat AP, editor. Ryan’s Retina. 6th ed. USA: Elsevier; 2019. p. 1993.
13. Cantor LB, Rapuano CJ, McCannel CA. Retina and Vitreous. In: Basic and Clinical Science Course. San Fransisco: American Academy of Ophthalmology; 2020.
14. Pan X, Fan N, Lie X. Easily Ignored Signs of Non-Arteritic Anterior Ischemic Optic Neuropathy: Secondary Serous Detachment in the Macula. In: Wang N, editor. Optic Disorders and Visual Field. Singapore: Springer; 2019. p. 369–76.
15. Tawse KL, Hedges TR, Gobuty M, Mendoza-Santiesteban C. Optical coherence tomography shows retinal abnormalities associated with optic nerve disease. Br J Ophthalmol. 2014;98(SUPPL. 2).
16. Sharma S, Ang M, Najjar RP, Sng C, Cheung CY, Rukmini A V, et al. Optical coherence tomography angiography in acute non-arteritic anterior ischaemic optic neuropathy. 2017;1045–51.
17. Yu C, Ho JK, Liao YJ. Subretinal fluid is common in experimental non-arteritic anterior ischemic optic neuropathy. Eye. 2014;28(12):1494–501.
18. Kanra AY, Uslu H. A preliminary diagnosis need to be considered as a differential diagnosis of submacular fluid: Non-arteritic ischemic optic neuropathy-case report. Retina-Vitreus. 2020;29(1):84–7.
19. Hayreh SS. Ischemic Optic Neuropathies. Springer; 2011.
20. Galvez-Ruiz A. Macular star formation in diabetic patients with non-arteritic anterior ischemic optic neuropathy (NA-AION). Saudi J Ophthalmol [Internet]. 2015;29(1):71–5. Available from: http://dx.doi.org/10.1016/j.sjopt.2014.09.002
21. Ayhan Z, Kocaoğlu G, Yaman A, Bajin MS, Saatci AO. Single Intravitreal Aflibercept Injection for Unilateral Acute Nonarteritic Ischemic Optic Neuropathy. Case Rep Ophthalmol Med. 2015;2015:1–4.
22. Chen YY, Chou P, Huang YF, Chien HJ, Wu YC, Lee CC, et al. Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy. BMC Ophthalmol. 2019;19(1):1–7.
23. Mansour AM, Schwartz SG, Gregori NZ, Yehoshua Z. Insight Into 8 Patients With Nonarteritic Anterior. J Neuro-ophthalmol. 2012;(32):189–93.
24. Saatci AO, Taskin O, Selver OB, Yaman A, Bajin MS. Efficacy of Intravitreal Ranibizumab Injection in Acute Nonarteritic Ischemic Optic Neuropathy: A Long-Term Follow Up. Open Ophthalmol J. 2013;7(1):58–62.